Millenium Pharma SPRL
4.3 FTEThe score of Millenium Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +34 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Millenium Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 105,304 € | ||||
| Equity | 288,316 € | ||||
| Cash | 149,706 € | ||||
| EBITDA | 176,855 € | ||||
| Total assets | €1.15m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
Millenium Pharma's financial analysis
- Solvency25.1%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Millenium Pharma
Millenium Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0467.724.694
- VAT number
- BE0467724694
- Peppol
- Registered · 0208:0467724694 · as of 31 Oct 2026
- Legal form
- SPRL
- Incorporated
- 30 Nov 1999
- Registered office
- 1083 Ganshoren
- Size
- Micro · 4.3 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Millenium Pharma (SPRL) has been based in Ganshoren since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 105,304 € and equity of 288,316 €; its revenue is not published. With 4.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 25.1%, below the median of its sector (37.8%).
Companies similar to Millenium Pharma
Companies in the same business, of comparable size and area, outside its group.
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Apotheek I. DE Bauw Retail sale of pharmaceutical products Putte · balance sheet €1.14m
- Pharmacie C. Bernard Retail sale of pharmaceutical products Seraing · balance sheet €1.28m
- America Nieuwerkerken Retail sale of pharmaceutical products Nieuwerkerken (Limb.) · balance sheet €1.44m
- LES Pharmacies Lambrechts Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 896,725 €
- Apo-M Retail sale of pharmaceutical products Kortenberg · balance sheet 852,674 €
- HDfarma Retail sale of pharmaceutical products Zedelgem · balance sheet 779,162 €
- Biloba Heverlee Retail sale of pharmaceutical products Leuven · balance sheet 760,814 €
Frequently asked questions about Millenium Pharma
What is the revenue of Millenium Pharma?
Millenium Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Millenium Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0467724694 for Millenium Pharma, if the company is VAT-registered. Its company number (CBE) is 0467.724.694.
Where is the registered office of Millenium Pharma?
According to the CBE register, the registered office of Millenium Pharma is in 1083 Ganshoren.
What is the equity of Millenium Pharma?
At the close of the 2025 financial year, the equity of Millenium Pharma amounts to 288,316 €, a solvency of 25.1% of total assets.
How many people work at Millenium Pharma?
4.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Millenium Pharma?
The register lists 3 active mandates at Millenium Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Millenium Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →